LymphedemaV1, Main, Exploration, bibRecord, 003C80

Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND

Identifieur interne : 003C80 ( Main/Exploration ); précédent : 003C79; suivant : 003C81

Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND

Auteurs : Nafisa Kayam Kuwajerwala [États-Unis] ; Claire Feczko [États-Unis] ; Nayana Dekhne [États-Unis] ; Jane Pettinga [États-Unis] ; Victoria C. Lucia [États-Unis] ; Justin Riutta [États-Unis] ; Frank Vicini

Source :

American journal of clinical oncology [ 0277-3732 ] ; 2013.

RBID : Pascal:13-0097750

Descripteurs français

Pascal (Inist)
- Etude comparative, Lymphoedème, Homme, Complication, Ganglion axillaire, Lymphadénectomie, Ganglion sentinelle, Biopsie, Anatomopathologie, Traitement.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Anatomic pathology, Axillary ganglion, Biopsy, Comparative study, Complication, Human, Lymphadenectomy, Lymphedema, Sentinel lymph node, Treatment.

Abstract

Purpose: The purpose of the study was to show that delayed axillary lymph node dissection (ALND) has higher rates of lymphedema compared with immediate ALND, using data from NSABP-B32 at Beaumont Hospital. Method: NSABP B-32 at Beaumont had 207 patients with follow-up data on 199 patients, randomizing clinically negative axilla to sentinel lymph node biopsy (SLNB)+ALND (GrA N=98), and SLNB+cytology±ALND (GrB N = 101). All patients had preoperative volumetric arm measurements and only node negatives had routine postoperative measurements assessing lymphedema for 36 months. We contacted node-positive patients for postoperative measurements for this study. Twenty-four and 15 cytology-positive patients had SLNB+ALND in GrA and GrB, respectively (SubGrA1 N=24; SubGrB1 N=15). Fourteen hematoxylin and eosin-positive patients had delayed ALND (SubGrB2a N = 14). Results: Lymphedema rate for node-positive SLNB+ALND was 10.3% [SubGrA1 (3/24)+SubGrB1 (1/15)=4/39] and node-negative SLNB+ ALND was 6.8% (SubGrA2=5/74). Lymphedema was 14.3% for delayed ALND in SubGrB2a (2 of 14) and 0% for 72 SLNBs in SubGrB2b. Our study comparing immediate and delayed ALND lymphedema was not statistically significant (10.3% vs. 14.3%, P= 0.65). Comparing node-negative ALND (SubGrA2= 5/74=6.8%) to node-positive ALND (A1+B1+B2a = 6/53 = 11.3%) was not statistically significant (P = 0.52). Comparing lymphedema for node-negative ALND (SubGrA2) to SLNB (SubGrB2b) only approached significance (6.8% vs. 0%, P=0.058). Conclusions: The rate of lymphedema was higher in delayed ALND but not statistically significant. Comparison, however, is difficult, given the limited sample size. We urge the other centers of NSABP-B32 to validate this, by contacting the node-positive patients for measurements. The lymphedema rate for SLNB alone was 0% and approached statistical significance when compared with node-negative ALND.

Affiliations:

États-Unis

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000038
to stream PascalFrancis, to step Curation: 000917
to stream PascalFrancis, to step Checkpoint: 000037
to stream Main, to step Merge: 003C90
to stream Main, to step Curation: 003C80

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND</title>
<author><name sortKey="Kayam Kuwajerwala, Nafisa" sort="Kayam Kuwajerwala, Nafisa" uniqKey="Kayam Kuwajerwala N" first="Nafisa" last="Kayam Kuwajerwala">Nafisa Kayam Kuwajerwala</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Feczko, Claire" sort="Feczko, Claire" uniqKey="Feczko C" first="Claire" last="Feczko">Claire Feczko</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Cancer Clinical Trials</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Department of Cancer Clinical Trials</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dekhne, Nayana" sort="Dekhne, Nayana" uniqKey="Dekhne N" first="Nayana" last="Dekhne">Nayana Dekhne</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pettinga, Jane" sort="Pettinga, Jane" uniqKey="Pettinga J" first="Jane" last="Pettinga">Jane Pettinga</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lucia, Victoria C" sort="Lucia, Victoria C" uniqKey="Lucia V" first="Victoria C." last="Lucia">Victoria C. Lucia</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Research Institute, William Beaumont Hospital</s1>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Research Institute, William Beaumont Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Riutta, Justin" sort="Riutta, Justin" uniqKey="Riutta J" first="Justin" last="Riutta">Justin Riutta</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physical Medicine and Rehabilitation, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0097750</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0097750 INIST</idno>
<idno type="RBID">Pascal:13-0097750</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000038</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000917</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000037</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000037</idno>
<idno type="wicri:doubleKey">0277-3732:2013:Kayam Kuwajerwala N:comparison:of:lymphedema</idno>
<idno type="wicri:Area/Main/Merge">003C90</idno>
<idno type="wicri:Area/Main/Curation">003C80</idno>
<idno type="wicri:Area/Main/Exploration">003C80</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND</title>
<author><name sortKey="Kayam Kuwajerwala, Nafisa" sort="Kayam Kuwajerwala, Nafisa" uniqKey="Kayam Kuwajerwala N" first="Nafisa" last="Kayam Kuwajerwala">Nafisa Kayam Kuwajerwala</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Feczko, Claire" sort="Feczko, Claire" uniqKey="Feczko C" first="Claire" last="Feczko">Claire Feczko</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Cancer Clinical Trials</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Department of Cancer Clinical Trials</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dekhne, Nayana" sort="Dekhne, Nayana" uniqKey="Dekhne N" first="Nayana" last="Dekhne">Nayana Dekhne</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pettinga, Jane" sort="Pettinga, Jane" uniqKey="Pettinga J" first="Jane" last="Pettinga">Jane Pettinga</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lucia, Victoria C" sort="Lucia, Victoria C" uniqKey="Lucia V" first="Victoria C." last="Lucia">Victoria C. Lucia</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Research Institute, William Beaumont Hospital</s1>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Research Institute, William Beaumont Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Riutta, Justin" sort="Riutta, Justin" uniqKey="Riutta J" first="Justin" last="Riutta">Justin Riutta</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physical Medicine and Rehabilitation, William Beaumont Hospital</s1>
<s2>Troy and Royal Oak</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Troy and Royal Oak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name>
</author>
</analytic>
<series><title level="j" type="main">American journal of clinical oncology</title>
<title level="j" type="abbreviated">Am. j. clin. oncol.</title>
<idno type="ISSN">0277-3732</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">American journal of clinical oncology</title>
<title level="j" type="abbreviated">Am. j. clin. oncol.</title>
<idno type="ISSN">0277-3732</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anatomic pathology</term>
<term>Axillary ganglion</term>
<term>Biopsy</term>
<term>Comparative study</term>
<term>Complication</term>
<term>Human</term>
<term>Lymphadenectomy</term>
<term>Lymphedema</term>
<term>Sentinel lymph node</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Etude comparative</term>
<term>Lymphoedème</term>
<term>Homme</term>
<term>Complication</term>
<term>Ganglion axillaire</term>
<term>Lymphadénectomie</term>
<term>Ganglion sentinelle</term>
<term>Biopsie</term>
<term>Anatomopathologie</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose: The purpose of the study was to show that delayed axillary lymph node dissection (ALND) has higher rates of lymphedema compared with immediate ALND, using data from NSABP-B32 at Beaumont Hospital. Method: NSABP B-32 at Beaumont had 207 patients with follow-up data on 199 patients, randomizing clinically negative axilla to sentinel lymph node biopsy (SLNB)+ALND (GrA N=98), and SLNB+cytology±ALND (GrB N = 101). All patients had preoperative volumetric arm measurements and only node negatives had routine postoperative measurements assessing lymphedema for 36 months. We contacted node-positive patients for postoperative measurements for this study. Twenty-four and 15 cytology-positive patients had SLNB+ALND in GrA and GrB, respectively (SubGrA1 N=24; SubGrB1 N=15). Fourteen hematoxylin and eosin-positive patients had delayed ALND (SubGrB2a N = 14). Results: Lymphedema rate for node-positive SLNB+ALND was 10.3% [SubGrA1 (3/24)+SubGrB1 (1/15)=4/39] and node-negative SLNB+ ALND was 6.8% (SubGrA2=5/74). Lymphedema was 14.3% for delayed ALND in SubGrB2a (2 of 14) and 0% for 72 SLNBs in SubGrB2b. Our study comparing immediate and delayed ALND lymphedema was not statistically significant (10.3% vs. 14.3%, P= 0.65). Comparing node-negative ALND (SubGrA2= 5/74=6.8%) to node-positive ALND (A1+B1+B2a = 6/53 = 11.3%) was not statistically significant (P = 0.52). Comparing lymphedema for node-negative ALND (SubGrA2) to SLNB (SubGrB2b) only approached significance (6.8% vs. 0%, P=0.058). Conclusions: The rate of lymphedema was higher in delayed ALND but not statistically significant. Comparison, however, is difficult, given the limited sample size. We urge the other centers of NSABP-B32 to validate this, by contacting the node-positive patients for measurements. The lymphedema rate for SLNB alone was 0% and approached statistical significance when compared with node-negative ALND.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Kayam Kuwajerwala, Nafisa" sort="Kayam Kuwajerwala, Nafisa" uniqKey="Kayam Kuwajerwala N" first="Nafisa" last="Kayam Kuwajerwala">Nafisa Kayam Kuwajerwala</name>
</noRegion>
<name sortKey="Dekhne, Nayana" sort="Dekhne, Nayana" uniqKey="Dekhne N" first="Nayana" last="Dekhne">Nayana Dekhne</name>
<name sortKey="Feczko, Claire" sort="Feczko, Claire" uniqKey="Feczko C" first="Claire" last="Feczko">Claire Feczko</name>
<name sortKey="Lucia, Victoria C" sort="Lucia, Victoria C" uniqKey="Lucia V" first="Victoria C." last="Lucia">Victoria C. Lucia</name>
<name sortKey="Pettinga, Jane" sort="Pettinga, Jane" uniqKey="Pettinga J" first="Jane" last="Pettinga">Jane Pettinga</name>
<name sortKey="Riutta, Justin" sort="Riutta, Justin" uniqKey="Riutta J" first="Justin" last="Riutta">Justin Riutta</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C80 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003C80 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:13-0097750
   |texte=   Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND

Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri